Colgate-Palmolive Company (NYSE:CL) Shares Sold by CWA Asset Management Group LLC

CWA Asset Management Group LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 80.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,473 shares of the company's stock after selling 26,369 shares during the period. CWA Asset Management Group LLC's holdings in Colgate-Palmolive were worth $607,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $27,000. Vermillion Wealth Management Inc. purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $31,000. Union Bancaire Privee UBP SA bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Finally, Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive during the fourth quarter valued at approximately $32,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded down $0.44 during mid-day trading on Tuesday, hitting $88.23. The stock had a trading volume of 4,539,127 shares, compared to its average volume of 4,788,116. The firm has a market cap of $71.50 billion, a PE ratio of 24.92, a PEG ratio of 4.66 and a beta of 0.38. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. The company has a 50 day moving average of $91.38 and a two-hundred day moving average of $90.71. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period in the prior year, the company earned $0.86 earnings per share. The company's revenue was down 3.0% on a year-over-year basis. Research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.36%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Colgate-Palmolive announced that its board has approved a stock repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Wells Fargo & Company upped their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Barclays decreased their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. Citigroup lifted their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research note on Monday, April 28th. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Finally, UBS Group lifted their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $102.12.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.